Comparing HER2 positive and HER2 negative cancers we identified that HER2 positivity is associated with enrichment of CD4 T cells and less proliferating CD4 Th cells and proliferating CD8 T cells compared to HER2 negative tumors. Here, CD4 is linked to cancer.